王海钠 - 山东大学

个人简介

2013.9-2014.9 美国国立卫生研究院国家癌症研究所访问学者 2013.9-至今山东大学药学院药物分析教研室，副教授 2006.8-2013.8 山东大学药学院药物分析教研室，讲师 2006.9-2011.12 浙江大学药学院药物分析学专业，医学博士 2003.7-2006.7 山东大学药学院药物分析教研室，助教 2000.9-2003.6 山东大学药学院药物分析学专业，硕士 1995.9-1999.7 山东医科大学药学院，学士

研究领域

1.手性药物分析 2. 药物质量控制 3. 药物代谢与代谢组学

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.Fang ZZ,Tosh DK,Tanaka N,Wang HN, et al. Metabolic mapping of A3 adenosine receptor agonist MRS5980, Biochemical Pharmacology, 2015; 97(2):215-223. 2.Jia L,Hu C,Wang HN, et al. Chirality Influence of Zaltoprofen Towards UDP-Glucuronosyltransferases (UGTs) Inhibition Potential, Chirality, 2015; 27(6):359-363. 3. Fang ZZ,Wang HN, Cao YF, et al. Enantioselective inhibition of carprofen towards UDP-glucuronosyltransferase (UGT)2B7, Chirality, 2015; 27(3):189-193. 4.Wang HN, Fang ZZ, Zheng Y, et al. Metabolic profiling of praziquantel enantiomers. Biochemical Pharmacology, 2014; 90(2):166-178. 5.Wang HN, Dong SQ, Xu H, et al. Genetic variants in FTO associated with metabolic syndrome: a meta- and gene-based analysis. Mol. Biol. Rep., 2012; 39:5691-5698. 6. Fang SM,Wang HN, Zhao ZX, Wang WH, Immobilized enzyme reactors in HPLC and its application in inhibitor screening: A review, Journal of Pharmaceutical Analysis, 2012, 2(2):83-89. 7.Wang HN, Yuan LM, Zeng S. Characterizing the effect of UDP-Glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen. Biochemical Pharmacology, 2011; 82(11):1757-1763. 8.Wang HN, Ji JB, Zeng S. Biosynthesis and stereoselective analysis of (-)- and (+)-zaltoprofen glucuronide in rat hepatic microsomes and its application to the kinetic analysis. Journal of chromatography B, 2011; 879(24): 2430-2436.